FDA-Approved

MetaDerm

MetaDerm is a topical approved for the treatment of psoriasis.

Ultravate (halobetasol propionate)

Ultravate is a topical ointment approved for the treatment of psoriasis.

Humira (adalimumab)

Humira is a biologic approved for the treatment of psoriasis, psoriatic arthritis, Crohn's disease, and rheumatoid arthritis.

Taclonex (calcipotriene/betamethasone dipropionate)

Taclonex is a topical suspension approved for the treatment of psoriasis. 

Acthar (repository corticotropin)

Acthar is a biologic approved as a short-term add-on therapy to treat psoriatic arthritis.

Ilumya (tildrakizumab-asmn)

Ilumya is a biologic that was approved for the treatment of psoriasis in 2018. It is also being tested as a treatment for psoriatic arthritis.

Enbrel (etanercept)

Enbrel is a biologic approved for the treatment of moderate to severe psoriasis and psoriatic arthritis.

Simponi Aria (golimumab)

Simponi Aria is a biologic approved for the treatment of psoriatic arthritis.

Simponi (golimumab)

Simponi is a biologic approved for the treatment of psoriatic arthritis. 

Sernivo (betamethasone dipropriate)

Sernivo is a topical spray that was approved for the treatment of psoriasis in 2016.

Pages